PATENT CLAIM ANALYSIS

Application Number: 15959318
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "234200"]

Abstract:
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

Claim (Index 12):
The method according to  claim 1 , wherein said cancer is acute myeloid leukemia, fibrosarcoma, myxosarcoma, liposarcoma, chondrosarcoma, osteogenic sarcoma, chordoma, angiosarcoma, endothelium sarcoma, lymphangiosarcoma, lymphangioendothelioma, lymphoid cancer, marrow cancer, bone cancer, sarcoma, periosteoma, mesothelioma, Ewing's tumor, leiomyosarcoma, rhabdomyosarcoma, skin cancer, laryngeal cancer, colon carcinoma, pancreatic cancer, renal cancer, bladder cancer, renal cell carcinoma, hepatocellular carcinoma, breast cancer, ovarian cancer, colorectal cancer, head cancer, neck cancer, prostatic carcinoma, testicular cancer, squamous cell carcinoma, basal cell carcinoma, adenocarcinoma, sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma, papillary adenocarcinoma, cystadenocarcinoma, medullary carcinoma, cholangiocarcinoma, choriocarcinoma, seminoma, embryonal carcinoma, Wilms' tumor, cervical cancer, orchioncus, lung cancer, small-cell lung cancer, lung adenocarcinoma, bronchogenic carcinoma, epithelial cancer, gastric mucosa disorders, ischemic bowel disease management, enteritis/colitis, cancer chemotherapy, neutropenia, sprouting angiogenesis, intussusceptive angiogenesis, vasculogenesis, arteriogenesis and lymphangiogenesis.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.16216
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13755617', '13120438', '14750019', '13120440', '13734205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8365131277782902
- 35 USC 102 Novelty (BERT): 0.6318867008345205
- Combined Prediction Score: 0.8160504850839133
- Mean Citation Score: 637.4256419999998
- Max Citation Score: 646.59875
- Similarity Product: 517.6328846398741

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test